Avoro Capital Advisors LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $6.65 Billion distributed in 36 stocks.
Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $1.02B, Ascendis Pharma A/S with a value of $745M, Argenx Se with a value of $672M, Krystal Biotech, Inc. with a value of $477M, and Madrigal Pharmaceuticals, Inc. with a value of $431M.
Examining the 13F form we can see an decrease of $680M in the current position value, from $7.33B to 6.65B.
Avoro Capital Advisors LLC is based out at New York, NY
Below you can find more details about Avoro Capital Advisors LLC portfolio as well as his latest detailed transactions.